Key facts
- NasaClip’s last known valuation is $16.0M (Mar 2024).
- It has raised $7.3M across 1 recorded rounds; the latest was Accelerator/Incubator in Jan 2022.
- Notable investors include US National Science Foundation, Springboard Enterprises, TEDCO, BCBS Health Equity Business Accelerator, Citrine Angels — 12 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for NasaClip
Funding rounds
1 roundsAbout NasaClip
Developer of a medical device designed to help control nosebleeds in children and adults. The company's nasal clip comes in adjustable sizes and applies constant hands-free pressure to the soft side walls of the nose and incorporates pre-medicated sponges to help deliver vasoconstrictive medication that can control bleeding, enabling healthcare professionals to improve the lives of patients and provide patients with an optional facial cooling pack to help constrict vessels and reduce inflammation.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2015
- Employees
- 7
- Website
- nasaclip.com/
- Ownership
- Privately Held (backing)
NasaClip doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NasaClip shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NasaClip in its N-PORT filings yet. We sweep new filings monthly.